INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults living with HIV-1 who had not previously received antiretroviral ...
In an era of overt sexism in the sciences, she made two major discoveries, including identifying a chemical signal in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results